pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A

被引:135
作者
Dai, JD
Nagai, T
Wang, XQ
Zhang, T
Meng, M
Zhang, Q
机构
[1] Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100083, Peoples R China
[2] Hoshi Univ, Dept Pharmaceut, Tokyo 1420063, Japan
[3] N China Pharmacet Grp Co Ltd, Inst Pharmaceut, Shijiazhuang, Peoples R China
关键词
cyclosporine A; pH-sensitive naroparticles; poly(methacrylic acid and methacrylate) copolymer; neoral microemulsion; in vitro; release; oral bioavailability;
D O I
10.1016/j.ijpharm.2004.05.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this work was to improve the oral bioavailability of cyclosporine A (CyA) by preparation the CyA-pH sensitive nanoparticles. The CyA-pH sensitive nanoparticles were prepared by using poly(methacrylic acid and methacrylate) copolymer. The characterization and the dispersion state of CyA at the surface or inside the polymeric matrices of the nanoparticles were investigated. The in vitro release studies were conducted by ultracentrifuge method. The bioavailability of CyA from nanoparticles and Neoral microemulsion was assessed in Sprague-Dawley (SD) rats at a dose of 15 mg/kg. The particle size of the nanoparticles was within the range from 37.4 +/- 5.6 to 106.7 +/- 14.8 nm. The drug entrapped efficiency was very high (from 90.9 to 99.9%) and in all cases the drug was amorphous or molecularly dispersed within the nanoparticles polymeric matrices. In vitro release experiments revealed that the nanoparticles exhibited perfect pH-dependant release profiles. The relative bioavailability of CyA was markedly increased by 32.5% for CyA-S100 nanoparticles (P < 0.05), and by 15.2% and 13.6% for CyA-L100-55 and CyA-L100 nanoparticles respectively, while it was decreased by 5.2% from CyA-E100 nanoparticles when compared with the Neoral microemulsion. With these results, the potential of pH-sensitive nanoparticles for the oral delivery of CyA was confirmed. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 36 条
[1]   TRANSMUCOSAL PASSAGE OF POLYALKYLCYANOACRYLATE NANOCAPSULES AS A NEW DRUG CARRIER IN THE SMALL-INTESTINE [J].
APRAHAMIAN, M ;
MICHEL, C ;
HUMBERT, W ;
DEVISSAGUET, JP ;
DAMGE, C .
BIOLOGY OF THE CELL, 1987, 61 (1-2) :69-76
[2]   CYCLOSPORINE AS A NEW APPROACH TO THERAPY OF AUTOIMMUNE-DISEASES [J].
BOREL, JF ;
GUNN, HC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 475 :307-319
[3]  
CAVANAK T, 1986, PROG ALLERGY, V38, P65
[4]   Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH [J].
Charman, WN ;
Porter, CJH ;
Mithani, S ;
Dressman, JB .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :269-282
[5]   Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles:: effect of the particle size and nutritional state [J].
De Jaeghere, F ;
Allémann, E ;
Kubel, F ;
Galli, B ;
Cozens, R ;
Doelker, E ;
Gurny, R .
JOURNAL OF CONTROLLED RELEASE, 2000, 68 (02) :291-298
[6]   THE ABSORPTION SITE OF CYCLOSPORINE IN THE HUMAN GASTROINTESTINAL-TRACT [J].
DREWE, J ;
BEGLINGER, C ;
KISSEL, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (01) :39-43
[7]   Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A [J].
El-Shabouri, MH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :101-108
[8]   Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery [J].
Hebert, MF .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 27 (2-3) :201-214
[9]   UNUSUAL SOLUBILITY BEHAVIOR OF CYCLOSPORINE-A IN AQUEOUS-MEDIA [J].
ISMAILOS, G ;
REPPAS, C ;
DRESSMAN, JB ;
MACHERAS, P .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (04) :287-289
[10]   NANOSPHERE AND MICROSPHERE UPTAKE VIA PEYER PATCHES - OBSERVATION OF THE RATE OF UPTAKE IN THE RAT AFTER A SINGLE ORAL DOSE [J].
JANI, PU ;
MCCARTHY, DE ;
FLORENCE, AT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 86 (2-3) :239-246